Hannah P. Yang
Staff Scientist
Cancer Epidemiology & Genetics
National Cancer Institute
United States of America
Biography
In the Office of the Director, Dr. Hannah P. Yang supports the planning of a new prospective multi-center cohort study that will serve as an important Division-wide resource. She also assists Deputy Division Director Montserrat García-Closas on other Division-related activities. Dr. Yang received her B.S. in biology and the history and sociology of science from the University of Pennsylvania, and her Sc.M. and Ph.D. in epidemiology from the Johns Hopkins Bloomberg School of Public Health. She joined DCEG as a pre-doctoral fellow in 2007 and completed her doctoral work through the Hopkins-DCEG partnership training program in cancer epidemiology. Upon completion of her doctorate, she became a postdoctoral fellow (2009-2011) and then a research fellow (2011-2012). She was appointed as a staff scientist in 2012. Dr. Yang has received several awards for her work, including DCEG awards for Outstanding Research Paper by a Staff Scientist (2013, 2015) and the CCR and DCEG award for Outstanding Poster at the Staff Scientist and Staff Clinician Retreat (2015)
Research Interest
"Epidemiology of female cancers; Molecular epidemiology; Applied/translational research "
Publications
-
Yang HP, Murphy KR, Pfeiffer RM, George N, Garcia-Closas M, Lissowska J, Brinton LA, Wentzensen N. Lifetime number of ovulatory cycles and risks of ovarian and endometrial cancer among postmenopausal women. American journal of epidemiology. 2016 Apr 15;183(9):800-14
-
Yang HP, Gonzalez Bosquet J, Li Q, Platz EA, Brinton LA, Sherman ME, Lacey Jr JV, Gaudet MM, Burdette LA, Figueroa JD, Ciampa JG. Common genetic variation in the sex hormone metabolic pathway and endometrial cancer risk: pathway-based evaluation of candidate genes. Carcinogenesis. 2010 Jan 6;31(5):827-33.
-
Yang HP, Zuna RE, Schiffman M, Walker JL, Sherman ME, Landrum LM, Moxley K, Gold MA, Dunn ST, Allen RA, Zhang R. Clinical and pathological heterogeneity of cervical intraepithelial neoplasia grade 3. PLoS One. 2012 Jan 13;7(1):e29051.
